Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro

Experimental Cell Research

Volumn 283, Issue 2, 2003, Pages 206-214

  Premzl, Aleš ^a   Zavašnik Bergant, Valentina ^a   Turk, Vito ^a   Kos, Janko ^a,b  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b KRKA D D   (Slovenia)

Author keywords

Cathepsin B; Extracellular matrix; Invasion; Monoclonal antibody; Quenched fluorescent substrate

Indexed keywords

ANTINEOPLASTIC AGENT; CATHEPSIN B; CATHEPSIN L; CYSTEINE PROTEINASE INHIBITOR; MONOCLONAL ANTIBODY; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE;

ARTICLE; BREAST EPITHELIUM; CELL LINE; CHICKEN; CONTROLLED STUDY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

GALLUS GALLUS; MINK CELL FOCUS-FORMING VIRUS;

EID: 0037442576     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(02)00055-1     Document Type: Article

References (43)

1. Woodhouse E.C., Chuaqui R.F., Liotta L.A. General mechanisms of metastasis. Cancer Suppl. 80:1997;1529-1537.
2. Andreasen P.A., Egelund R., Petersen H.H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 57:2000;25-40.
3. Rochefort H., Liaudet-Coopman E. Cathepsin D in cancer metastasis A protease and a ligand (review article) . APMIS. 107:1999;86-95.
4. Kos J., Lah T.T. Cysteine proteinases and their endogenous inhibitors Target proteins for prognosis, diagnosis and therapy in cancer (review) . Oncol. Rep. 5:1998;1349-1361.
5. Johansson N., Ahonen M., Kähäri V.-M. Matrix metalloproteinases in tumor invasion. Cell. Mol. Life Sci. 57:2000;5-15.
6. Demchik L.L., Sameni M., Nelson K., Mikkelsen T., Sloane B.F. Cathepsin B and glioma invasion. Int. J. Dev. Neurosci. 17:1999;483-494.
7. Strojnik T., Židanik B., Kos J., Lah T.T. Cathepsins B and L are markers for clinically invasive types of meningiomas. Neurosurgery. 48:2001;598-605.
8. Dohchin A., Suzuki J.I., Seki H., Masutani M., Shiroto H., Kawakami Y. Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Cancer. 89:2000;482-487.
9. Yan S., Sameni M., Sloane B.F. Cathepsin B and human tumor progression. Biol. Chem. 379:1998;113-123.
10. Buck M.R., Karustis D.G., Day N.A., Honn K.V., Sloane B.F. Degradation of extracellular matrix proteins by human cathepsin B from normal and tumour tissues. Biochem. J. 282:1992;273-278.
11. Guinec N., Dalet-Fumeron V., Engler R. In vitro study of basement membrane degradation by cysteine proteinases, cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronectin, and release of gelatinase activities from basement membrane fibronectin. Biol. Chem. Hoppe-Seyler. 374:1993;1135-1146.
12. Creemers L.B., Hoeben K.A., Jansen D.C., Buttle D.J., Beertsen W., Everts V. Participation of intracellular cysteine proteinases, in particular cathepsin B, in degradation of collagen in periosteal tissue explants. Matrix Biol. 16:1997;575-584.
13. Kobayashi H., Schmitt M., Goretzki L., Chucholowski N., Calvete J., Kramer M., Gunzler W.A., Janicke F., Graeff H. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J. Biol. Chem. 266:1991;5147-5152.
14. Schmitt M., Jänicke F., Graeff H. Tumor-associated proteases. Fibrinolysis. 6:(Suppl. 4):1992;3-26.
15. Kobayashi H., Moniwa N., Sugimura M., Shinohara H., Ohi H., Terao T. Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes. Biochim. Biophys. Acta. 1178:1993;55-62.
16. Keppler D., Sloane B.F. Cathepsin B Multiple enzyme forms from a single gene and their relation to cancer . Enzyme Protein. 49:1996;94-105.
17. Linebaugh B.E., Sameni M., Day N.A., Sloane B.F., Keppler D. Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. Eur. J. Biochem. 264:1999;100-109.
18. Sinha A.A., Jamuar M.P., Wilson M.J., Rozhin J., Sloane B.F. Plasma membrane association of cathepsin B in human prostate cancer biochemical and immunogold electron microscopic analysis . Prostate. 49:2001;172-184.
19. Sloane B.F., Moin K., Sameni M., Tait L.R., Rozhin J., Ziegler G. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J. Cell Sci. 107:1994;373-384.
20. Montcourrier P., Mangeat P.H., Salazar G., Morisset M., Sahuquet A., Rochefort H. Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res. 50:1990;6045-6054.
21. Montcourrier P., Mangeat P.H., Valembois C., Salazar G., Sahuquet A., Duperray C., Rochefort H. Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J. Cell Sci. 107:1994;2381-2391.
22. Ahram M., Sameni M., Qiu R.-G., Linebaugh B., Kirn D., Sloane B.F. Rac1-induced endocytosis is associated with intracellular proteolysis during migration through a three-dimensional matrix. Exp. Cell Res. 260:2000;292-303.
23. Szpaderska A.M., Frankfater A. An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res. 61:2001;3493-3500.
24. Soule H.D., Maloney T.M., Wolman S.R., Peterson W.D. Jr., Brenz R., McGrath C.M., Russo J., Pauley R.J., Jones R.F., Brooks S.C. Isolations and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50:1990;6075-6086.
25. Basolo F., Elliot J., Tait L., Chen Q.C., Maloney T.M., Russo I.H., Pauley R., Momiki S., Caamano J., Klein-Szanto A.J.P., Koszalka M., Russo J. Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol. Carcinogen. 4:1991;25-35.
26. Kos J., Dolinar M., Turk V. Isolation and characterisation of chicken L- and H-kininogens and their interaction with chicken cysteine proteinases and papain. Agents Actions (Suppl.). 38:1992;331-339.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival Application to proliferation and cytotoxicity assays . J. Immunol. Methods. 65:1983;55-63.
28. Schweiger A., Štabuc B., Popovič T., Turk V., Kos J. Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera. J. Immunol. Methods. 201:1997;165-172.
29. Holst-Hansen C., Brünner N. MTT-cell proliferation assay. Celio J.E. Cell Biology A Laboratory Handbook . 1998;Academic Press, San Diego.
30. Holst-Hansen C., Johannessen B., Højer-Hansen G., Romer J., Ellis V., Bünner N. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin. Exp. Metastasis. 14:1996;297-307.
31. Achkar C., Gong Q., Frankfater A., Bajkowski A.S. Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney sarcoma virus-transformed BALB/3T3 fibroblasts. J. Biol. Chem. 265:1990;13650-13654.
32. Qian F., Bajkowski A.S., Steiner D.F., Chan S.J., Frankfater A. Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues. Cencer Res. 49:1989;4870-4875.
33. Sameni M., Moin K., Sloane B.F. Imaging proteolysis by living human breast cancer cells. Neoplasia. 2:2000;496-504.
34. Premzl A., Puizdar V., Zavašnik-Bergant T., Kopitar-Jerala N., Lah T.T., Katunuma N., Sloane B.F., Turk V., Kos J. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases. Biol. Chem. 382:2001;853-857.
35. Ochieng J., Basolo F., Albini A., Melchiori A., Watanabe H., Elliott J., Raz A., Parodi S., Russo J. Increased invasive, chemotactic and locomotive abilities of c-HA-ras transformed human breast epithelial cells. Invasion Metastasis. 11:1991;38-47.
36. Lah T.T., Bervar A., Zajc I., Sever N., Levičar N., Filipič M., Kos J. Cathepsins B and L and their inhibitors in relation to invasiveness and tumorigenicity of human breast tumor cell lines. Int. J. Biol. Markers. 15:2000;S27.
37. Dawson P.J., Wolman S.R., Tait L., Heppner G.H., Miller F.R. MCF10AT A model for the evolution of cancer from proliferative breast disease . Am. J. Pathol. 148:1996;313-319.
38. Miller F.R., Soule H.D., Tait L., Pauley R.J., Wolman S.R., Dawson P.J., Heppner G.H. Xenograft model of human proliferative breast disease. J. Natl. Cancer Inst. 85:1993;1725-1732.
39. Sameni M., Dosescu J., Sloane B.F. Imaging proteolysis by living human glioma cells. Biol. Chem. 382:2001;785-788.
40. Coopman P.J., Do M.T., Thompson E.W., Mueller S.C. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin. Cancer Res. 4:1998;507-515.
41. Mai J., Finley R.L. Jr., Waisman D.M., Sloane B.F. Human Procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J. Biol. Chem. 275:2000;12806-12812.
42. Buttle D.J., Murata M., Knight C.G., Barrett A.J. CA074 methyl ester A proinhibitor for intracellular cathepsin B . Arch. Biochem. Biophys. 299:1992;377-380.
43. Pardridge W.M., Buciak J., Yang J., Wu D. Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody after cationization of the protein. J. Pharmacol. Exp. Ther. 286:1998;548-554.